2022 annual financial data
Sinovac Biotech 2022 Net margin
Direct answer
Net margin was 7.63%.
Operating income was -466,067,000 USD and net income was 113,866,000 USD.
Operating cash flow was -770,745,000 USD.
Get free Sinovac Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,492,761,000 USD
- Operating income
- -466,067,000 USD
- Net income
- 113,866,000 USD
- Operating cash flow
- -770,745,000 USD